Fisher Asset Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-349,239
Closed -$405K 1213
2023
Q2
$405K Sell
349,239
-53,950
-13% -$62.6K ﹤0.01% 891
2023
Q1
$609K Sell
403,189
-39
-0% -$59 ﹤0.01% 831
2022
Q4
$1.01M Buy
403,228
+222,347
+123% +$556K ﹤0.01% 770
2022
Q3
$763K Sell
180,881
-300
-0.2% -$1.27K ﹤0.01% 711
2022
Q2
$505K Buy
181,181
+300
+0.2% +$836 ﹤0.01% 717
2022
Q1
$1.04M Buy
180,881
+49,387
+38% +$283K ﹤0.01% 623
2021
Q4
$1.2M Buy
131,494
+96,487
+276% +$881K ﹤0.01% 617
2021
Q3
$374K Buy
35,007
+100
+0.3% +$1.07K ﹤0.01% 770
2021
Q2
$542K Buy
34,907
+185
+0.5% +$2.87K ﹤0.01% 706
2021
Q1
$563K Buy
34,722
+1,644
+5% +$26.7K ﹤0.01% 688
2020
Q4
$700K Sell
33,078
-6,535
-16% -$138K ﹤0.01% 649
2020
Q3
$587K Sell
39,613
-17,850
-31% -$265K ﹤0.01% 628
2020
Q2
$845K Sell
57,463
-8,236
-13% -$121K ﹤0.01% 589
2020
Q1
$771K Sell
65,699
-9,637
-13% -$113K ﹤0.01% 568
2019
Q4
$1.77M Buy
75,336
+77
+0.1% +$1.81K ﹤0.01% 510
2019
Q3
$1.39M Hold
75,259
﹤0.01% 585
2019
Q2
$1.4M Buy
75,259
+8,016
+12% +$149K ﹤0.01% 580
2019
Q1
$1.64M Hold
67,243
﹤0.01% 544
2018
Q4
$1.74M Hold
67,243
﹤0.01% 540
2018
Q3
$2.13M Sell
67,243
-24,832
-27% -$786K ﹤0.01% 511
2018
Q2
$3.58M Sell
92,075
-19,426
-17% -$755K ﹤0.01% 476
2018
Q1
$3.08M Sell
111,501
-9,568
-8% -$264K ﹤0.01% 487
2017
Q4
$2.19M Buy
121,069
+20,705
+21% +$375K ﹤0.01% 513
2017
Q3
$1.62M Buy
+100,364
New +$1.62M ﹤0.01% 524